BioAge Labs, Inc.

BIOA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001709941

SEC filings (opens in a new tab)

No open-market purchases or sales by BioAge Labs, Inc. insiders were filed in the last 90 days; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding BioAge Labs, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of BIOA: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Q3 2024	Change
Holders	0	58	+58
Shares	0	20.7M	+20.7M
Value	$0	$430.8M	+$430.8M

New holders (58)

Institutions that held BioAge Labs, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to BIOA in Q3 2024
Institution	Shares	Value	% of portfolio
AH Capital Management, L.L.C.	3,013,975	$62.7M	5.51%
Sofinnova Investments, Inc.	2,304,901	$47.9M	3.97%
Ra Capital Management, L.P.	2,210,589	$46.0M	0.53%
Cormorant Asset Management, LP	1,629,529	$33.9M	1.80%
Suvretta Capital Management, LLC	1,455,000	$30.3M	1.09%
OrbiMed Advisors LLC	1,423,470	$29.6M	0.54%
Sands Capital Ventures, LLC	1,086,353	$22.6M	6.35%
Alliancebernstein L.P.	994,315	$20.7M	0.01%
RTW Investments, LP	786,353	$16.4M	0.24%
Pivotal bioVenture Partners Investment Advisor LLC	527,647	$11.0M	6.51%
Price T Rowe Associates Inc	449,837	$9.36M	0.00%
Redpoint Management, LLC	383,255	$7.97M	1.49%
Brown Advisory Inc	334,915	$6.97M	0.01%
Siren, L.L.C.	300,000	$6.24M	0.31%
Emerald Advisers, LLC	281,317	$5.85M	0.23%
Comprehensive Financial Management LLC	271,842	$5.65M	0.16%
Wasatch Advisors Inc	254,907	$5.30M	0.03%
Emerald Mutual Fund Advisers Trust	229,431	$4.77M	0.25%
Citadel Advisors LLC	213,718	$4.45M	0.00%
JPMorgan Chase & Co	200,000	$4.16M	0.00%
FIL Ltd	200,000	$4.16M	0.00%
Marshall Wace, LLP	200,000	$4.16M	0.01%
Millennium Management LLC	166,022	$3.45M	0.00%
Alyeska Investment Group, L.P.	150,000	$3.12M	0.02%
Healthcare of Ontario Pension Plan Trust Fund	150,000	$3.12M	0.01%
Zimmer Partners, LP	125,000	$2.60M	0.05%
Woodline Partners LP	124,950	$2.60M	0.02%
Balyasny Asset Management LLC	120,000	$2.50M	0.01%
Howard Hughes Medical Institute	113,765	$2.37M	0.38%
Goldman Sachs Group Inc	108,616	$2.26M	0.00%
Soros Fund Management LLCSuperinvestorSoros Fund Management	100,000	$2.08M	0.04%
Silverarc Capital Management, LLC	100,000	$2.08M	0.47%
Monashee Investment Management LLC	95,000	$1.98M	0.21%
Walleye Capital LLC	76,875	$1.60M	0.02%
TD Asset Management Inc	59,678	$1.25M	0.00%
Point72 (DIFC) Ltd	55,080	$1.15M	0.09%
Platinum Investment Management Ltd	50,000	$1.04M	0.05%
Jane Street Group, LLC	43,073	$895.9K	0.00%
Norges Bank	40,000	$832.0K	0.00%
Vanguard Group Inc	40,000	$832.0K	0.00%
Squarepoint Ops LLC	36,314	$755.3K	0.00%
Ghisallo Capital Management LLC	30,000	$624.0K	0.03%
Kodai Capital Management LP	30,000	$624.0K	0.01%
Manufacturers Life Insurance Company, The	26,677	$554.9K	0.00%
Maven Securities LTD	25,000	$520.0K	0.06%
Teacher Retirement System of Texas	20,000	$416.0K	0.00%
Valor Management LLC	13,105	$272.6K	0.06%
Landscape Capital Management, L.L.C.	12,643	$263.0K	0.03%
Barclays PLC	11,900	$247.5K	0.00%
Two Sigma Investments, LP	11,500	$239.2K	0.00%
HRT Financial LP	9,813	$204.0K	0.00%
Aster Capital Management (DIFC) Ltd	6,988	$145.3K	0.03%
Point72 Asset Management, L.P.	2,700	$56.2K	0.00%
Morgan Stanley	2,309	$48.0K	0.00%
Parallel Advisors, LLC	731	$15.2K	0.00%
Bank of America Corp	525	$10.9K	0.00%
Tower Research Capital LLC (TRC)	37	$770	0.00%
Advisor Group Holdings, Inc.	33	$686	0.00%

Sold out (0)

Institutions that held BioAge Labs, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

None.